Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This product is a **combination drug** consisting of three components: saline (sterile sodium chloride solution), ketoprofen, and paracetamol. **Ketoprofen** is a non-steroidal anti-inflammatory drug (NSAID) that acts by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, reducing the production of prostaglandins responsible for pain, inflammation, and fever. **Paracetamol** (also known as acetaminophen) is an analgesic and antipyretic that works primarily in the central nervous system to inhibit prostaglandin synthesis, providing pain and fever relief. **Saline** is used as a vehicle or diluent for intravenous or other parenteral administration, ensuring isotonicity and compatibility with body fluids. The combination of ketoprofen and paracetamol is known to provide more effective analgesia with a faster onset compared to either agent alone and is used for acute pain management, often in the postoperative setting[1][2]. Combination products including both ketoprofen and paracetamol are marketed in some countries, sometimes with additional excipients or vehicles such as saline[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saline + ketoprofen + paracetamol.